Frank Tori named FDA chief scientist

Apr 09, 2008

The U.S. Food and Drug Administration has appointed Dr. Frank Torti as its principal deputy commissioner and new chief scientist.

FDA Commissioner Dr. Andrew von Eschenbach said the newly created chief scientist position was mandated by the Food and Drug Administration Amendments Act of 2007.

"Dr. Torti's impressive clinical and scientific credentials are an excellent match for the work we do on a daily basis to promote and protect the nation's health as a science-based and science-led agency," von Eschenbach said. "FDA's chief scientist will ensure that the foundation of the FDA's regulatory structure will always be state-of-the-art science."

A clinician, scientist and researcher in molecular oncology, Torti is currently serving as a professor at the Wake Forest University School of Medicine in Winston-Salem, N.C.

Torti received his bachelor's and master's degrees from Johns Hopkins University, his medical degree from Harvard Medical School and his master of public health degree from the Harvard School of Public Health.

He will assume his new post next month.

Copyright 2008 by United Press International

Explore further: Cardinal Health paying $26.8 million in FTC settlement

Related Stories

Traffic court goes digital: Startup fosters settlements

Mar 31, 2015

Traffic court is going digital. Michigan startup Court Innovations has developed a software solution that allows drivers to settle traffic violations by negotiating in a virtual environment instead of showing up to court ...

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

21 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.